Literature DB >> 16724978

Outcome of cirrhotic patients undergoing cholecystectomy: applying Bayesian analysis in gastroenterology.

Eduardo B V da Silveira1.   

Abstract

BACKGROUND AND AIM: Cholelithiasis is a common finding in patients with cirrhosis. Previous studies showed that open cholecystectomy (OC) carries a high risk of postoperative complications and deaths in cirrhotic patients. Laparoscopic cholecystectomy (LC) has significantly decreased hospital stay and postoperative morbidity in non-cirrhotic patients. The aim of this study was to evaluate the outcomes of cirrhotic patients after LC and OC in a tertiary center.
METHODS: The outcomes of 33 cirrhotic patients matched by age and sex to 66 non-cirrhotic controls who underwent cholecystectomy were assessed using Bayesian analysis. Both non-informative and informative priors were used to calculate posterior distributions for parameters under investigation.
RESULTS: Twenty-four (72%) cirrhotic patients had LC and 9 (27%) OC. A similar percentage of patients in the control group underwent LC (78%) and OC (21%). Emergent cholecystectomy was not different between cirrhotic and controls (95% credible interval [CrI]-0.35, 0.02). Mean blood loss, duration of surgery and conversion rate was not different between cirrhotic and controls, but cirrhotic patients had a longer length of hospital stay than controls (CrI 0.88, 4.71). Cirrhotic patients undergoing LC had lower volume of blood loss (CrI -363.85 mL, -49.28 mL), shorter duration of surgery (CrI -79.82 min, -19.74 min), lower amount of intravenous fluid during surgery (CrI -1532.9 mL, -495.4 mL) and shorter hospital stay (CrI -11.14 days, -1.20 days) than cirrhotic patients undergoing OC. Child-Pugh class B class and admission diagnosis of biliary pancreatitis were associated with a longer hospital stay.
CONCLUSION: Laparoscopic cholecystectomy is a safe and effective alternative to OC in Child-Pugh class A and B cirrhotic patients undergoing elective or emergent cholecystectomy. Although outcomes of cirrhotic patients undergoing LC and OC in a tertiary center are not different, LC is associated with less intraoperative bleeding, shorter duration of surgery and fewer days of in-hospital care.

Entities:  

Mesh:

Year:  2006        PMID: 16724978     DOI: 10.1111/j.1440-1746.2006.04227.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  5 in total

1.  Management of common bile duct stones in cirrhotic patients with coagulopathy: a comparison of supra-papillary puncture and standard cannulation technique.

Authors:  Everson L A Artifon; Eduardo B da Silveira; Dayse Aparicio; Jonas Takada; Renato Baracat; Christiano M Sakai; Ruel T Garcia; Vanessa Teich; Decio S Couto
Journal:  Dig Dis Sci       Date:  2011-02-12       Impact factor: 3.199

Review 2.  Laparoscopic or open cholecystectomy in cirrhosis: a systematic review of outcomes and meta-analysis of randomized trials.

Authors:  Jerome M Laurence; Peter D Tran; Arthur J Richardson; Henry C C Pleass; Vincent W T Lam
Journal:  HPB (Oxford)       Date:  2012-01-18       Impact factor: 3.647

3.  Laparoscopic cholecystectomy in cirrhotic patients with symptomatic cholelithiasis: a case-control study.

Authors:  Jorge Marcelo Padilla Mancero; Luiz Augusto Carneiro D'Albuquerque; Adriano Miziara Gonzalez; Frans Ivan Serpa Larrea; Adavio de Oliveira e Silva
Journal:  World J Surg       Date:  2008-02       Impact factor: 3.352

Review 4.  Procedure-related bleeding risk in patients with cirrhosis and severe thrombocytopenia.

Authors:  Domenico Alvaro; Nicola Caporaso; Edoardo Giovanni Giannini; Angelo Iacobellis; Mariacristina Morelli; Pierluigi Toniutto; Francesco Violi
Journal:  Eur J Clin Invest       Date:  2021-02-26       Impact factor: 4.686

5.  Delayed laparoscopic cholecystectomy is safe and effective for acute severe calculous cholecystitis in patients with advanced cirrhosis: a single center experience.

Authors:  Zhicheng Yao; Kunpeng Hu; Pingzhu Huang; He Huang; Xingui Chen; Peisheng Yang; Bo Liu
Journal:  Gastroenterol Res Pract       Date:  2014-03-19       Impact factor: 2.260

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.